Aeglea is a Texas-based clinical-stage biotechnology company that develops enzyme therapies for the treatment of metabolic diseases.
Business Model:
Revenue: $5.8M
Employees: 51-200
Address: 805 Las Cimas Parkway
City: Austin
State: TX
Zip: 78746
Country: US
Aeglea is a Texas-based clinical-stage biotechnology company that develops enzyme therapies for the treatment of metabolic diseases.
Contact Phone:
+15129422935
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/7/2016
Ticker Symbol:
AGLE
IPO Price:
$10/share
Amount Raised:
$50M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2014 | Series A | $0 |
KBI Biopharma Lilly Ventures UT Horizon Fund Novartis Venture Fund KBI Biopharma Lilly Ventures UT Horizon Fund Novartis Venture Fund |
3/2015 | Series B | 11 | $44M |
UT Horizon Fund Lilly Ventures Rock Springs Capital Jennison Associates Ally Bridge Group OrbiMed Venrock Cowen Healthcare Investments New Ground Ventures Novartis Venture Fund Lilly Ventures Novartis Venture Fund RA Capital Management UT Horizon Fund Lilly Ventures Rock Springs Capital Jennison Associates Ally Bridge Group OrbiMed Venrock Cowen Healthcare Investments New Ground Ventures Novartis Venture Fund Lilly Ventures Novartis Venture Fund |
3/2014 | Unattributed | $12M | 2/2014 | Series A | 4 | $12M |
Lilly Ventures Lilly Ventures |
---|
Announced Date | Name | Price |
---|---|---|
6/2023 | Sayre Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|